Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens
Antibiotics · 02.09.2024 · 13 (9) · 834
DOI: 10.3390/antibiotics13090834 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 02.09.2024. Verfasst von Blanca Lorente-Torres und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MCIN/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR, Junta de Castilla y León, MCIN/AEI/10.13039/501100011033.
Abstract (Originalsprache)
Intracellular bacterial pathogens pose significant public health challenges due to their ability to evade immune defenses and conventional antibiotics. Drug repurposing has recently been explored as a strategy to discover new therapeutic uses for established drugs to combat these infections. Utilizing high-throughput screening, bioinformatics, and systems biology, several existing drugs have been identified with potential efficacy against intracellular bacteria. For instance, neuroleptic agents like thioridazine and antipsychotic drugs such as chlorpromazine have shown effectiveness against Staphylococcus aureus and Listeria monocytogenes. Furthermore, anticancer drugs including tamoxifen and imatinib have been repurposed to induce autophagy and inhibit bacterial growth within host cells. Statins and anti-inflammatory drugs have also demonstrated the ability to enhance host immune responses against Mycobacterium tuberculosis. The review highlights the complex mechanisms these pathogens use to resist conventional treatments, showcases successful examples of drug repurposing, and discusses the methodologies used to identify and validate these drugs. Overall, drug repurposing offers a promising approach for developing new treatments for bacterial infections, addressing the urgent need for effective antimicrobial therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain.
- Instituto de Biología Molecular, Genómica y Proteómica (INBIOMIC), Universidad de León, 24071 León, Spain.
- Instituto de Desarrollo Ganadero y Sanidad Animal (INDEGSAL), Universidad de León, 24071 León, Spain.
ORCID-Profile: Blanca Lorente-Torres, Jesús Llano-Verdeja, Pablo Castañera, Helena Á Ferrero, Sergio Fernández-Martínez, Luis M Mateos, Michal Letek, Álvaro Mourenza
Förderung
- MCIN/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR
- Junta de Castilla y León
- MCIN/AEI/10.13039/501100011033
- Junta de Castilla y León (JCyL), Spain
- Spanish Ministry of Education
- FPU fellowship
- ULE
- AECC summer scholarship
Zitieren
APA
Lorente-Torres, B., Llano-Verdeja, J., Castañera, P., Ferrero, H. Á., Fernández-Martínez, S., Javadimarand, F., Mateos, L. M., Letek, M., & Mourenza, Á. (2024). Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens. Antibiotics, 13(9), 834. https://doi.org/10.3390/antibiotics13090834
Vancouver
Lorente-Torres B, Llano-Verdeja J, Castañera P, Ferrero HÁ, Fernández-Martínez S, Javadimarand F, et al. Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens. Antibiotics. 2024;13(9):834. doi:10.3390/antibiotics13090834
BibTeX
@article{LorenteTorres2024,
author = {Lorente-Torres, Blanca and Llano-Verdeja, Jesús and Castañera, Pablo and Ferrero, Helena Á and Fernández-Martínez, Sergio and Javadimarand, Farzaneh and Mateos, Luis M and Letek, Michal and Mourenza, Álvaro},
title = {Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens},
journal = {Antibiotics},
year = {2024},
volume = {13},
number = {9},
pages = {834},
doi = {10.3390/antibiotics13090834}
}
EUVIMED